Legal Opinion
ENCORE DERMATOLOGY INC. v. GLENMARK PHARMACEUTICALS LIMITED
District Court, D. New Jersey
Decided December 22, 2020No. 2:20-cv-02509Unknown
1Opinion
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY ENCORE DERMATOLOGY INC., Plaintiff, Civ. No. 20-02509 (KM) (ESK) v. OPINION GLENMARK PHARMACEUTICALS LIMITED, Defendant. KEVIN MCNULTY, U.S.D.J.: Encore Dermatology has a patent for a topical pharmaceutical composition with the compound clobetasol. The patent also provides that the composition is “propylene glycol-free.” Glenmark Pharmaceuticals filed an Abbreviated New Drug Application (“ANDA”) with the Food and Drug Administration (“FDA”), seeking approval for a clobetasol cream that contains propylene glycol. Encore then sued…
2Cases cited23 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- R+L Carriers, Inc. v. DriverTech LLCCourt of Appeals for the Federal Circuit · 2012
18 more not listed; retrieve them via the Exa API.